Ftse Mib
37.977,59
0,18%
DAX
22.513,42
-0,43%
S&P 500
6.114,63
-0,01%
NASDAQ
20.026,77
0,41%
Bitcoin
97.690,23
0,17%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Roche Holding Ag (0QQ6) Roche Holding Ag (0QQ6) Notizie

Roche Holding Ag

0QQ6
229,20
0,00 (0,00%)
14 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: Londra
Tipo: Azione Ordinaria
Valuta: CHF

Ultime notizie

Data Ora Fonte Titolo
12/2/202517:45UKREGFDA approves Roche’s Evrysdi tablet as first and only tablet..
07/2/202509:45UKREGNew England Journal of Medicine publishes new data for..
04/2/202517:45UKREGFDA approves Roche’s Susvimo as the first and only..
31/1/202517:45UKREGRoche receives FDA approval for the first companion..
30/1/202507:00UKREG[Ad hoc announcement pursuant to Art. 53 LR] Roche reports..
30/1/202507:00UKREG[Ad-hoc-Mitteilung gemäss Art. 53 KR] Roche erzielt starkes..
29/1/202507:00UKREGChange to the Roche Enlarged Corporate Executive Committee
28/1/202507:00UKREGRoche’s Itovebi demonstrated statistically significant and..
27/1/202507:00UKREGRoche announces new results from EMBARK demonstrating..
22/1/202507:00UKREGRoche receives FDA clearance with CLIA waiver for cobas®..
08/1/202507:10UKREGRoche purchases shares in tender offer for Poseida..
19/12/202407:00UKREGRoche’s Phase IIb study of prasinezumab missed primary..
18/12/202407:00UKREGRoche transforms mass spectrometry diagnostics with launch..
13/12/202407:10UKREGRoche’s Vabysmo prefilled syringe (PFS) approved in the EU..
13/12/202407:00UKREGRoche receives CE Mark for new and updated molecular cobas..
10/12/202407:00UKREGNew and updated data for Roche's fixed-duration Columvi and..
09/12/202422:30UKREGRoche commences tender offer for all shares of Poseida..
08/12/202418:30UKREGFive-year results confirm Roche’s Polivy combination therapy..
05/12/202407:00UKREGFDA accepts supplemental Biologics License Application for..
26/11/202407:10UKREGRoche enters into a definitive agreement to acquire Poseida..
26/11/202407:00UKREGRoche reports update on Phase III SKYSCRAPER-01 study..
05/11/202415:15UKREGRoche to present new and encouraging long-term follow-up..
31/10/202407:15UKREGRoche presents new data at CTAD, demonstrating its growing..
31/10/202407:00UKREGNew England Journal of Medicine publishes landmark phase III..
23/10/202411:58IHMARKETNEWSUS Futures Fall Amid Treasury Yield Surge and Earnings; Oil..
23/10/202407:00UKREG[Ad hoc-Mitteilung gemäss Art. 53 KR] Starkes..
23/10/202407:00UKREG[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong..
18/10/202423:00UKREGRoche’s Vabysmo improved vision in underrepresented..
14/10/202407:00UKREGMajority of children with spinal muscular atrophy (SMA)..
11/10/202407:00UKREGFDA approves Roche’s Itovebi, a targeted treatment for..
10/10/202407:00UKREGRoche obtains CE certification for the first companion..
26/9/202407:00UKREGPositive phase III results for Roche’s Gazyva/Gazyvaro show..
24/9/202407:00UKREGRoche launches the first test to use its breakthrough TAGS..
23/9/202407:00UKREGWHO endorses dual-stain cytology (CINtec PLUS) testing in..
19/9/202407:00UKREGPositive phase III results show Xofluza significantly..
16/9/202407:00UKREGFDA approves OCREVUS ZUNOVO™ as the first and only..
13/9/202407:00UKREGFDA approves Roche’s Tecentriq Hybreza, the first and only..
10/9/202416:00UKREGRoche opens Pharma Research and Development Center in Basel..
10/9/202416:00UKREGRoche eröffnet Pharmaforschungs- und Entwicklungszentrum in..
04/9/202408:00UKREGRoche’s fenebrutinib demonstrated near-complete suppression..
27/8/202407:00UKREGRoche’s PiaSky approved in the EU as the first monthly..
20/8/202414:30UKREGRoche responds to WHO’s declaration of a global health..
30/7/202407:00UKREGEuropean Commission approves Roche’s Vabysmo for treatment..
29/7/202407:00UKREGRoche closes acquisition of LumiraDx’s Point of Care..
25/7/202407:00UKREG[Ad hoc announcement pursuant to Art. 53 LR] Roche sales..
18/7/202413:20UKREGNew data for Roche’s Susvimo demonstrates sustained efficacy..
17/7/202417:45UKREGRoche’s Vabysmo showed extended durability, continued..
17/7/202407:00UKREG[Ad hoc announcement pursuant to Art. 53 LR] Roche announces..
09/7/202407:00UKREGRoche receives CE Mark for its AI-enabled continuous glucose..
08/7/202417:45UKREGRoche to reintroduce Susvimo in the US for people with..
Apertura: Min: Max:
Chiusura: 229,20

La tua Cronologia

LSE
0QQ6
Roche
BIT
UB4Q9Z
Unicredit Bank
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci